Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 1.53B | 1.51B | 1.34B | 1.36B | 1.37B | 1.24B |
| Cost of revenue | 665M | 674M | 653M | 640M | 639M | 589M |
| Research and development | 478M | 453M | 443M | 424M | 413M | 406M |
| Selling, general and administrative | 221M | 251M | 250M | 235M | 221M | 229M |
| Operating expenses | 1.60B | 1.64B | 1.60B | 1.56B | 1.55B | 1.49B |
| Operating income | −74M | −128M | −260M | −194M | −173M | −254M |
| Pre-tax income | −86M | −103M | −255M | −131M | −145M | −243M |
| Income tax | 3M | 510,000 | 8M | 8M | 8M | 5M |
| Net income | −89M | −104M | −263M | −140M | −153M | −249M |
| Earnings per share | −0.05 | −0.06 | −0.16 | −0.08 | −0.09 | −0.15 |
| Earnings per share, diluted | −0.05 | −0.06 | −0.16 | −0.08 | −0.09 | −0.15 |
| Weighted average shares | 1.69B | 1.70B | 1.67B | 1.70B | 1.66B | 1.64B |
| Weighted average shares, diluted | 1.69B | 1.70B | 1.67B | 1.70B | 1.66B | 1.64B |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.06B | 1.03B | 953M | 929M | 916M | 1.05B | 965M | 1.07B |
| Short-term investments | 1.76B | 1.91B |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 327M | 146M | 88M | 152M | 116M | −21M |
| Depreciation and amortisation | 45M | 43M | 40M | 38M | 39M | 38M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 2.04B |
| 1.97B |
| 2.30B |
| 2.33B |
| 2.23B |
| 2.02B |
| Receivables | 1.19B | 1.37B | 1.25B | 1.16B | 1.16B | 1.35B | 1.20B | 1.14B |
| Current assets | 4.28B | 4.58B | 4.48B | 4.28B | 4.58B | 4.91B | 4.59B | 4.42B |
| Property, plant and equipment | 581M | 578M | 557M | 544M | 501M | 489M | 466M | 444M |
| Goodwill | 1.75B | 1.72B | 1.72B | 1.72B | 1.69B | 1.69B | 1.69B | 1.69B |
| Total assets | 7.50B | 7.68B | 7.58B | 7.40B | 7.59B | 7.94B | 7.59B | 7.42B |
| Current liabilities | 1.21B | 1.29B | 1.22B | 1.10B | 1.06B | 1.24B | 1.14B | 1.11B |
| Short-term debt | 47M | 47M | 47M | 0 | 36M | 36M | — | — |
| Long-term debt | 3.49B | 3.49B | 3.49B | 3.58B | 3.58B | 3.61B | — | — |
| Total liabilities | 5.42B | 5.40B | 5.35B | 5.33B | 5.28B | 5.49B | 5.38B | 5.35B |
| Equity | 2.08B | 2.28B | 2.23B | 2.07B | 2.31B | 2.45B | 2.21B | 2.07B |
| Shares outstanding | 1.74B | 1.76B | 1.76B | 1.73B | 1.73B | 1.74B | 1.72B | 1.70B |
| Share-based compensation | 250M | 260M | 252M | 247M | 260M | 259M |
| Capital expenditure | 41M | 53M | 65M | 37M | 44M | 52M |
| Investing cash flow | 57M | −108M | 215M | 3M | −223M | −214M |
| Share buybacks | 350M | 0 | 243M | 257M | 0 | 76M |
| Financing cash flow | −352M | −12M | −291M | −289M | 10M | 237M |